A detailed history of State Of New Jersey Common Pension Fund D transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, State Of New Jersey Common Pension Fund D holds 38,196 shares of NBIX stock, worth $4.71 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
38,196
Previous 38,196 -0.0%
Holding current value
$4.71 Million
Previous $5.26 Million 16.38%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$130.86 - $143.19 $2.39 Million - $2.62 Million
-18,287 Reduced 32.38%
38,196 $5.26 Million
Q3 2022

Oct 28, 2022

SELL
$92.03 - $107.81 $117,246 - $137,349
-1,274 Reduced 2.21%
56,483 $6 Million
Q1 2022

May 03, 2022

SELL
$72.45 - $94.81 $185,254 - $242,429
-2,557 Reduced 4.24%
57,757 $5.42 Million
Q4 2021

Jan 31, 2022

BUY
$79.65 - $106.22 $112,625 - $150,195
1,414 Added 2.4%
60,314 $5.14 Million
Q3 2021

Oct 27, 2021

BUY
$86.18 - $99.03 $117,549 - $135,076
1,364 Added 2.37%
58,900 $5.65 Million
Q2 2021

Jul 23, 2021

BUY
$89.43 - $102.27 $108,657 - $124,258
1,215 Added 2.16%
57,536 $5.6 Million
Q1 2021

Apr 27, 2021

SELL
$87.57 - $119.4 $288,455 - $393,303
-3,294 Reduced 5.53%
56,321 $5.48 Million
Q4 2020

Feb 03, 2021

SELL
$86.91 - $108.33 $191,549 - $238,759
-2,204 Reduced 3.57%
59,615 $5.71 Million
Q3 2020

Oct 27, 2020

SELL
$96.16 - $135.15 $78,178 - $109,876
-813 Reduced 1.3%
61,819 $5.95 Million
Q2 2020

Aug 04, 2020

SELL
$85.09 - $130.36 $264,374 - $405,028
-3,107 Reduced 4.73%
62,632 $7.64 Million
Q4 2019

Jan 31, 2020

SELL
$86.8 - $118.57 $569,494 - $777,937
-6,561 Reduced 9.07%
65,739 $7.07 Million
Q3 2019

Oct 23, 2019

BUY
$83.82 - $101.5 $6.06 Million - $7.34 Million
72,300 New
72,300 $6.52 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.8B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track State Of New Jersey Common Pension Fund D Portfolio

Follow State Of New Jersey Common Pension Fund D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

News

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.